Upstream Bio (UPB) Gross Margin (2024 - 2026)

Upstream Bio's quarterly Gross Margin came in at 380.95% in Q1 2026, down 10480.0% year-on-year from N/an in Q1 2025, and up 66.84% quarter-over-quarter from 1148.8% in Q4 2025.

Upstream Bio has reported Gross Margin for 3 years, with the latest figure at 380.95% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 10480.0% year-over-year to 380.95%; the trailing twelve-month figure through Mar 2026 stood at 678.36% (down 40884.0% YoY), and the FY2025 full-year result was 706.34%, down 52870.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 380.95%, up from 1148.8% in the prior quarter.
  • The five-year high for Gross Margin was 45.16% in Q1 2024, with the low at 1148.8% in Q4 2025.
  • Average Gross Margin over 3 years is 420.78%, with a median of 276.15% recorded in 2025.
  • Peak annual rise in Gross Margin reached 1320 bps in 2025, while the deepest fall reached 79856 bps in 2025.
  • Tracing UPB's Gross Margin over 3 years: stood at 350.24% in 2024, then sank by 228 bps to 1148.8% in 2025, then soared by 67 bps to 380.95% in 2026.
  • The last three Gross Margin figures came in at 380.95% (Q1 2026), 1148.8% (Q4 2025), and 272.18% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 79.04%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 86.85%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 91.79%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 82.22%
10 Upstream Bio 454.22 Mn 454.22 Mn -3.94 Mn -380.95%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -380.95%
Dec 31, 2025 -1,148.80%
Sep 30, 2025 -272.18%
Jun 30, 2025 -967.24%
Mar 31, 2025 -276.15%
Dec 31, 2024 -350.24%
Sep 30, 2024 -258.98%
Jun 30, 2024 -177.65%
Mar 31, 2024 45.16%